CVAC Competitors & Alternatives
Compare CureVac NV with similar stocks in the same industry
Biotechnology
CVAC
Main Stock$4.66
Tradestie Score
58
Market Cap
$1.22B
P/E Ratio
7.0
Revenue Growth
-0.9%
Analyst Upside
+15.6%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NKTR
Nektar Therapeutics
|
$70.59
|
$1.12B | - | 63 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$305.51
|
$1.12B | - | 49 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.02
|
$1.09B | - | 48 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$9.82
|
$1.05B | 72.0 | 41 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.27
|
$1.01B | 103.3 | 53 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$5.46
|
$997.16M | - | 47 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$2.81
|
$996.55M | - | 59 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$94.93
|
$994.20M | - | 52 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.07
|
$993.46M | - | 47 | Compare |
|
IMNM
Immunome, Inc.
|
$23.01
|
$987.09M | - | 51 | Compare |
More CVAC Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry